A New Type of RNA Could Revolutionize Vaccines and Cancer Treatments
An accidental discovery turned into an unexpected success, when a team of interdisciplinary BU researchers created a new and improved COVID vaccine.
Modified Self-Amplifying RNA Provides Opportunities For New Vaccines And Treatments
A paper published on July 8, 2024 in the journal Nature Biotechnology presents promising data that offers a foundation for developing future vaccines and treatments.
After 30 years of decline, tuberculosis is rising in the U.S. again. How did we get here?
After declining for three decades, tuberculosis (TB) rates in the U.S. have been increasing steadily since 2020.
Is COVID-19 Still a Pandemic?
The Brink asked three Boston University researchers—a virologist, an epidemiologist, and an emergency room physician—to explain the shifting status of COVID, how to decide when a virus has gone from a pandemic to endemic, how much people should protect themselves and others, and why language matters.
Novel compound protects against infection by virus that causes COVID-19, preliminary studies show.
Compounds that obstruct the “landing gear” of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19 finds a new study from NEIDL researchers and the Dana-Farber Cancer Institute.
Virology, Immunology & Microbiology Professor Robert Davey awarded $3.3M per year for five years.
The NIH National Institute of Allergies and Infectious Diseases awarded…
It’s good to feel bad after your COVID shot
New research suggests that the worse your symptoms are after…
Researchers Find Potential Way to Tweak Immune System to Help It Fight Tuberculosis
Original article from The Brink by Andrew Thurston. September 27,…
After White House Stint, BU Infectious Diseases Expert Shares Pandemic Lessons
Original article from The Brink by Andrew Thurston. August 1,…
Inside Omicron with Mohsan Saeed
Mohsan Saeed joins This Week in Virology to discuss the…